
A major step for HCV research
Research team from Hannover adapts hepatitis C virus to infect mouse liver cells
We are investigating how the association of HCV with lipoproteins contributes to the persistence of the virus by influencing entry into liver cells and protecting against antibodies. The aim is to gain new insights for the development of an HCV vaccine.
We are investigating how antibodies protect against HCV infection, in particular what properties they have during a healing infection. The aim is to identify antibodies that are important for an effective vaccine against HCV.
The project investigates the factors that determine the species barrier mechanism of HCV and make it impossible to study the infection in animal models. The aim is to use genetic screening systems to develop in vivo models for vaccine research.
We develop high-throughput screening assays to identify antiviral molecules against RSV and SARS-CoV-2. We use compound libraries, investigate new mechanisms of action and strive for innovative therapies.
We are investigating why HCV infections sometimes heal spontaneously, but often become chronic, and why RSV infections are severe in some children. We use modern sequencing technologies to analyze the genetic characteristics of hosts and pathogens in order to understand susceptibility.
Research team from Hannover adapts hepatitis C virus to infect mouse liver cells
Group leader Chris Lauber funded by RESIST
RESIST-Scientist Professor Pietschmann, head of the TWINCORE Insitute for Experimental Virology, leads the German part of an international consortium of scientists. This research network is searching for substances that act against SARS-CoV-2 in the world's largest substance repurposing bank "ReFrame".
DZIF Press Release
Team led by TWINCORE virologist Pietschmann receives around 700,000 euros for RSV project
TWINCORE researchers discover promising drug candidate
Discovery of two novel classes of natural products with activity against RNA viruses
Statins do not increase infectivity or viral replication of SARS-CoV-2
New tool aims to make HCV vaccine search easier
Research team at TWINCORE, with international collaborators, clarifies why mice are not susceptible to infection with hepatitis C virus
Wissenschaftler des TWINCORE stören die Infektionskette des Hepatitis-C-Virus
Neutralising antibodies can prevent severe courses